These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 11735089

  • 1. Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice.
    Cohen MP, Lautenslager GT, Shearman CW.
    Metabolism; 2001 Dec; 50(12):1435-40. PubMed ID: 11735089
    [Abstract] [Full Text] [Related]

  • 2. Evolution of renal function abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy.
    Cohen MP, Clements RS, Hud E, Cohen JA, Ziyadeh FN.
    Exp Nephrol; 1996 Dec; 4(3):166-71. PubMed ID: 8773479
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
    Mima A, Arai H, Matsubara T, Abe H, Nagai K, Tamura Y, Torikoshi K, Araki M, Kanamori H, Takahashi T, Tominaga T, Matsuura M, Iehara N, Fukatsu A, Kita T, Doi T.
    Diabetes; 2008 Jun; 57(6):1712-22. PubMed ID: 18285555
    [Abstract] [Full Text] [Related]

  • 7. Effect of varied protein intake on the nephropathy of the diabetic mouse (C57BL/s J db/db).
    Brouhard BH, Rajaraman S, LaGrone LF.
    Int J Pediatr Nephrol; 1987 Jun; 8(2):59-68. PubMed ID: 3308729
    [Abstract] [Full Text] [Related]

  • 8. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
    Liao J, Kobayashi M, Kanamuru Y, Nakamura S, Makita Y, Funabiki K, Horikoshi S, Tomino Y.
    J Nephrol; 2003 Jun; 16(6):841-9. PubMed ID: 14736011
    [Abstract] [Full Text] [Related]

  • 9. Influence of C-peptide on early glomerular changes in diabetic mice.
    Maezawa Y, Yokote K, Sonezaki K, Fujimoto M, Kobayashi K, Kawamura H, Tokuyama T, Takemoto M, Ueda S, Kuwaki T, Mori S, Wahren J, Saito Y.
    Diabetes Metab Res Rev; 2006 Jun; 22(4):313-22. PubMed ID: 16389646
    [Abstract] [Full Text] [Related]

  • 10. Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency.
    Cohen MP, Lautenslager GT, Hud E, Shea E, Wang A, Chen S, Shearman CW.
    Am J Physiol Renal Physiol; 2007 Feb; 292(2):F789-95. PubMed ID: 17018845
    [Abstract] [Full Text] [Related]

  • 11. SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice.
    Sugaru E, Nakagawa T, Ono-Kishino M, Nagamine J, Tokunaga T, Kitoh M, Hume WE, Nagata R, Taiji M.
    Am J Physiol Renal Physiol; 2006 Apr; 290(4):F813-20. PubMed ID: 16278277
    [Abstract] [Full Text] [Related]

  • 12. Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice.
    Cohen MP, Hud E, Shea E, Shearman CW.
    Metabolism; 2002 Jul; 51(7):901-5. PubMed ID: 12077739
    [Abstract] [Full Text] [Related]

  • 13. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice.
    Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH.
    J Am Soc Nephrol; 2005 Jun; 16(6):1711-22. PubMed ID: 15857924
    [Abstract] [Full Text] [Related]

  • 14. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products.
    Zheng F, He C, Cai W, Hattori M, Steffes M, Vlassara H.
    Diabetes Metab Res Rev; 2002 Jun; 18(3):224-37. PubMed ID: 12112941
    [Abstract] [Full Text] [Related]

  • 15. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 16. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
    Ninichuk V, Kulkarni O, Clauss S, Anders H-.
    Eur J Med Res; 2007 Aug 16; 12(8):351-5. PubMed ID: 17933712
    [Abstract] [Full Text] [Related]

  • 17. Soluble betaglycan reduces renal damage progression in db/db mice.
    Juárez P, Vilchis-Landeros MM, Ponce-Coria J, Mendoza V, Hernández-Pando R, Bobadilla NA, López-Casillas F.
    Am J Physiol Renal Physiol; 2007 Jan 16; 292(1):F321-9. PubMed ID: 16954341
    [Abstract] [Full Text] [Related]

  • 18. 2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice.
    Ichinose K, Maeshima Y, Yamamoto Y, Kinomura M, Hirokoshi K, Kitayama H, Takazawa Y, Sugiyama H, Yamasaki Y, Agata N, Makino H.
    Diabetes; 2006 May 16; 55(5):1232-42. PubMed ID: 16644677
    [Abstract] [Full Text] [Related]

  • 19. Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms.
    Baba M, Wada J, Eguchi J, Hashimoto I, Okada T, Yasuhara A, Shikata K, Kanwar YS, Makino H.
    J Am Soc Nephrol; 2005 Nov 16; 16(11):3222-34. PubMed ID: 16177004
    [Abstract] [Full Text] [Related]

  • 20. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.
    Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D.
    J Am Soc Nephrol; 2006 Nov 16; 17(11):3067-75. PubMed ID: 17021266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.